PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1

Blood

Volumn 97, Issue 9, 2001, Pages 2908-2912

  Garrett Sinha, Lee Ann ^a,b,c   Dahl, Richard ^a,b,c   Rao, Sridhar ^a,b,c   Barton, Kevin P ^a,b,c   Celeste Simon, M ^a,b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CLONOGENIC ASSAY; EXTRAMEDULLARY HEMATOPOIESIS; FETUS LIVER; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPLEEN CELL; THYMUS;

EID: 0035353165     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.9.2908     Document Type: Article

References (25)

1. Bassuk AG, Leiden JM. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv Immunol. 1997;64:65-104.
2. Klemsz M, McKercher S, Celada A, Van Beveren C, Maki R. The macrophage and B cell-specific transcription factor PU.1 is related to the Ets oncogene. Cell. 1990;61:113-124.
3. Galson DL, Hensold JO, Bishop TR, et al. Mouse β-globin DNA binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/ PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol. 1993;13:2929-2941.
4. Hromas R, Orazi A, Neiman RS, et al. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood. 1993;82:2998-3004.
5. Chen H-M, Zhang P, Voso M, et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood. 1995;85:2918-2928.
6. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573-1577.
7. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15:5647-5658.
8. Su GH, Ip HS, Cobb BS, Lu M-M, Chen H-M, Simon MC. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J Exp Med. 1996;184:203-214.
9. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development. 1999;126:3131-3148.
10. Su GH, Chen H-M, Muthusamy N, et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 1997;16:7118-7129.
11. Kola I, Brookes S, Green AR, et al. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci U S A. 1993;90:7588-7592.
12. Maroulakou IG, Papas TS, Green JE. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene. 1994;9:1551-1565.
13. Bories JC, Willerford DM, Grevin D, et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 1995;377:635-638.
14. Muthusamy N, Barton K, Leiden JM. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 1995;377:639-642.
15. Barton K, Muthusamy N, Fischer C, et al. Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998;9:555-563.
16. Bassuk AG, Barton KP, Anandappa RT, Lu MM, Leiden JM. Expression pattern of the Ets-related transcription factor Elf-1. Mol Med. 1998;4:392-401.
17. c chain gene promoter depends upon an Ets binding site and is regulated by GA-binding protein. J Biol Chem. 1996;271:14849-14855.
18. Bockamp EO, Fordham JL, Gottgens B, Murrell AM, Sanchez MJ, Green AR. Transcriptional regulation of the stem cell leukemia gene by PU.1 and Elf-1. J Biol Chem. 1998;273:29032-29042.
19. John S, Robbins CM, Leonard WJ: An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 1996;15:5627-5635.
20. Ray D, Bosselut R, Ghysdael J, Mattei M, Tavitian A, Moreau-Gachelin F. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol. 1992;12:4297-4304.
21. Muller S, Sideras P, Smith CI, Xanthopoulos KG. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. Oncogene. 1996;13:1955-1964.
22. Garrett-Sinha LA, Su GH, Rao S, et al. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity. 1999;10:399-408.
23. Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA, Torbett, BE. Myeloid development is selectively disrupted in PU.1 null mice. Blood. 1998;91:3702-3710.
24. Fisher RC, Lovelock JD, Scott EW. A critical role for PU.1 in homing and long-term engraftment by hematopoietic stem cells in the bone marrow. Blood. 1999;94:1283-1290.
25. Scott EW, Fisher R, Olson M, Simon MC, Singh H. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity. 1997;6:437-447.